Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial public offering, set to be the first U.S.-based biotech firm to debut this ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...

Turing's 1950 paper didn't just pose the profound question, "Can machines think?". It ignited a quest to build AI technology ...

This optical illusion challenges users to spot a hidden number "2" amidst a sea of alphabets within 5 seconds. The brain ...

The technology to leverage healthcare data exists. The problem, according to Highlander Health, is outdated structures and ...

Jessica Thompson, an assistant professor of anthropology, has traveled to Malawi for summers to conduct fieldwork. But as a ...

The desire to rebuild the destroyed communities is strong. But residents know they cannot fully replace what has been lost ...

76 Navigate the invisible maze. Start by going right of the signpost ... meaning each letter in the alphabet corresponds to a number. If the code is HAHA, as the signpost says, then the real ...

Wandering through the aisles of the Marietta Antique Mall is like taking a stroll through history’s garage sale. Every turn reveals a new surprise – maybe a mid-century modern lamp that looks like it ...

Slowing growth in Alphabet's cloud business and a bigger-than-expected capex forecast for 2025 dragged shares down more than 8% in postmarket trading. The Google parent company, which reported ...

One thing analysts called out in their first-look notes on Alphabet's results was that the company's $75 billion capital-expense forecast came in higher than what many were modeling. The target ...